MedTrace Logo

L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia

NCT00469846 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 585

Last updated 2007-05-08

No results posted yet for this study

Summary

This study is intended to assess the efficacy of L-arginine supplementation with antioxidant vitamins delivered in a medical food in reducing the incidence of preeclampsia in a high-risk population.

Conditions

  • Pre-Eclampsia

Interventions

PROCEDURE

L-arginine supplementation in a medical food

PROCEDURE

Vitamin C and E supplementation in a medical food

Sponsors & Collaborators

  • University of Pennsylvania

    collaborator OTHER

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes

    lead OTHER_GOV

Principal Investigators

  • Felipe Vadillo-Ortega, M.D.,Ph.D. · Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
32 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Completion
2006-11-30

Countries

  • United States
  • Mexico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00469846 on ClinicalTrials.gov